ALLOGENE THERAPEUTICS INC

ALLO · NASDAQ

Updated at 2026-11-16 21:08:39

$0.80-3.77%
Today's High
$0.85
Today’s Low
$0.76
ALLOGENE THERAPEUTICS INC (ALLO) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$0.83
Previous Close
$0.83
Volume
11.66M
Market Cap
$290.58M
P/E Ratio
--
EPS
$-0.48

Previous Day Range

$0.82$0.86

52-Week Range

$0.82$4.46

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080
Country
US
Listing Date
2018-10-11
Fiscal Year End
December
Shares Outstanding
345.49M
CIK
0001737287

Allogene Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and markets genetically engineered allogeneic T-cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California.

Financial Metrics

Revenue

2026-09-30

$0

2026-06-30

$4.64M

2026-03-31

$0

2025-12-31

$0

Operating Expenses

2026-09-30

$54.79M

2026-06-30

$51.56M

2026-03-31

$46.09M

2025-12-31

$42.4M

Net Income

2026-09-30

-$50.36M

2026-06-30

-$42.67M

2026-03-31

-$42.6M

2025-12-31

-$38.81M

Net Profit Margin

2026-09-30

--

2026-06-30

-919.76%

2026-03-31

--

2025-12-31

--

Earnings Per Share

2026-09-30

$-0.15

2026-06-30

$-0.13

2026-03-31

$-0.18

2025-12-31

$-0.17

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

-$47.4M

2026-06-30

-$39.68M

2026-03-31

-$39.43M

2025-12-31

-$35.44M

Effective Tax Rate

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.